tiprankstipranks
Immuron Ltd (IMRN)
NASDAQ:IMRN
Holding IMRN?
Track your performance easily

Immuron (IMRN) Stock Price & Analysis

182 Followers

IMRN Stock Chart & Stats


Financials

Annual

Ownership Overview

0.03%99.97%
Insiders
Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

IMRN FAQ

What was Immuron Ltd’s price range in the past 12 months?
Immuron Ltd lowest stock price was $1.59 and its highest was $5.96 in the past 12 months.
    What is Immuron Ltd’s market cap?
    Currently, no data Available
    When is Immuron Ltd’s upcoming earnings report date?
    Immuron Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 96 days.
      How were Immuron Ltd’s earnings last quarter?
      Immuron Ltd released its earnings results on Aug 30, 2024. The company reported -$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.014.
        Is Immuron Ltd overvalued?
        According to Wall Street analysts Immuron Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Immuron Ltd pay dividends?
          Immuron Ltd does not currently pay dividends.
          What is Immuron Ltd’s EPS estimate?
          Immuron Ltd’s EPS estimate is -$0.01.
            How many shares outstanding does Immuron Ltd have?
            Immuron Ltd has 5,728,636 shares outstanding.
              What happened to Immuron Ltd’s price movement after its last earnings report?
              Immuron Ltd reported an EPS of -$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.376%.
                Which hedge fund is a major shareholder of Immuron Ltd?
                Currently, no hedge funds are holding shares in IMRN
                ---

                Immuron Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Company Description

                Immuron Ltd

                Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Cyclacel Pharmaceuticals
                Citius Pharmaceuticals
                Edesa Biotech
                GeoVax Labs

                Best Analysts Covering IMRN

                1 Year
                Unknown AnalystLitchfield Hills
                Not Ranked
                1 Year Success Rate
                0/0 ratings generated profit
                0%
                1 Year Average Return
                0.00%
                initiated a buy rating 2 months ago
                Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis